Peptide

PT-141 nasal research (bremelanotide routes)

Also known as

PT-141 nasal research · bremelanotide nasal · PT-141 nasal spray · intranasal PT-141 · intranasal bremelanotide · PT141 nose spray · PT-141 IN · bremelanotide intranasal spray · compounded PT-141 spray · nasal Vyleesi (misnomer)

Community talk. May contain inaccuracies. Not medical advice. Not a protocol. Not for human or animal use.

What it is

Nasal bremelanotide	PT-141 delivered as a spray, discussed for sexual desire and arousal without an injection.
Different from Vyleesi delivery	The approved injection and historical trial sprays do not validate a modern nasal bottle's amount, absorption or safety.

Notes

Nasal PT-141 is bremelanotide delivered as a spray, discussed for sexual desire and arousal without an injection. Reports range from warmth and greater sensitivity to no benefit, burning or nausea. Spray amounts and timing differ widely; the medical injection's evidence does not validate a nasal product.

Same peptide, different delivery. Bremelanotide activates melanocortin receptors, including receptors in the brain; its exact desire mechanism is unknown. Vyleesi is an injection for specified premenopausal low-desire disorder, not a nasal performance product. Vyleesi bremelanotide injection prescribing information (Official context · Accessed 2026-09-30)

Needle avoidance drives interest. People compare ready-made sprays, compounded liquids and improvised research sprays. A Drugs-Forum writer explicitly feared needles but obtained no effect nasally. Formulation, actuation and absorption make a spray count different from a known absorbed amount. Bremelanotide nasal spray troubleshooting (Personal report · Accessed 2026-09-30)

Clinic scripts are another source of numbers. The original clinic/community record includes a 1 mg-per-spray script with a 2 mg-per-occasion ceiling and broader 0.5–2 mg per-spray claims. These commercial conventions are not measured responder bands; old multi-milligram trial formulations cannot calibrate today's bottle.

Source context — Vyleesi bremelanotide injection prescribing information: Approved subcutaneous product and population; cannot validate modern sprays. No nasal adverse-event percentages inferred.

Source context — Bremelanotide nasal spray troubleshooting: One old unverified self-prepared product account; claimed bioavailability and absorption conversion unsupported. No formulation recipe or vendor request reproduced.

What people notice

Interest and sensitivity	Some report warmth, relaxation, easier sexual response, optimism or heightened touch sensitivity.
Mixed route experiences	One person reports strong nasal effects without injection-related nausea. Others describe flushing, burning or nausea without any desired change.

Notes

More interest or responsiveness. One nasal user described relaxation, warmth and easier sexual response; another described optimism and heightened touch sensitivity. These are different experiences, not proof that every spray produces desire or fixes erectile dysfunction. Interesting experience with Pt 141 nasal spray (Community discussion · Accessed 2026-09-30) · Female PT-141 experiences and compounded nasal replies (Community discussion · Accessed 2026-09-30)

Less nausea for some, unchanged for others. A route-comparison author reported strong sexual effects without the nausea experienced with injection. Elsewhere, four nasal sprays produced flushing and brief nausea but no desired change. A route switch does not predict tolerability or benefit. PT-141 experience (Community discussion · Accessed 2026-09-30) · Female PT-141 experiences and compounded nasal replies (Community discussion · Accessed 2026-09-30)

Burning and flushing can occur without benefit. One nasal user described intense burning for several minutes and discarded the spray after repeated failures. Another experienced hot flushing and ten minutes of nausea, then nothing. Feeling a side effect does not confirm effective delivery. Does PT-141 work? — nasal nonresponse replies (Community discussion · Accessed 2026-09-30) · Female PT-141 experiences and compounded nasal replies (Community discussion · Accessed 2026-09-30)

Source context — Interesting experience with Pt 141 nasal spray: Unverified nominal amounts and products; challenge is not an assay. Different authors, not controlled dose comparison. Blanket success/failure percentages and guaranteed injection claims rejected.

Source context — Female PT-141 experiences and compounded nasal replies: Nasal milligrams unspecified; co-medication and changed amount confound attribution. Wife's account is spouse-reported. Long-duration replies elsewhere omit route and are not assigned to nasal.

Source context — PT-141 experience: No nasal mass or concentration, no duration or assay. 2 mg reply does not identify route and is not used as a nasal dose. Self-mixing and purchase directions excluded. Nausea reply is not nasal-specific.

Source context — Does PT-141 work? — nasal nonresponse replies: No nasal amount, formulation or assay; only relevant route-explicit replies credited. Other injection or unspecified-route outcomes cannot establish nasal response or prevalence.

Doses people talk about

Separate spray reports	A claimed 1.25 mg across six sprays brought brief effects, with concentration disputed. Another account reports no effect from two labeled 1 mg sprays, nominally 2 mg.
100 mcg-per-spray products	Four or five sprays, nominally 400–500 mcg total, brought benefit in one account. Another couple reported none from a similarly labeled product, with total unstated.
Clinic scripts	A 1 mg-per-spray script with a 2 mg-per-occasion ceiling and broader 0.5–2 mg-per-spray claims appear. These are commercial conventions, not measured responder bands.
Historical trial formulations	Older nasal studies explored roughly 5–20 mg, unlike many modern compounded spray claims. These controlled formulations cannot calibrate a current bottle.

Notes

Nominal 1.25 mg versus 2 mg per occasion. One author claimed 1.25 mg across six sprays and a brief response; replies disputed the concentration. A different commenter reported no effect from two sprays labeled 1 mg each. These are separate unverified totals, not a useful dose ladder. Interesting experience with Pt 141 nasal spray (Community discussion · Accessed 2026-09-30)

100 mcg per spray, opposite outcomes. Another author reported four to five 100 mcg sprays, nominally 400–500 mcg total, with benefit. A couple using a 100 mcg-per-spray product reported none, without giving their total. Per-spray strength alone cannot compare exposures. Nasal pt141 is amazing (Community discussion · Accessed 2026-09-30)

Critical split — trial-era IN vs modern compounded IN: Early ED programs used multi-milligram nasal loads (often ~5–20 mg); many modern clinic sprays advertise ~0.5–2 mg total per occasion. These are not interchangeable mass numbers and may not share absorption or formulation. [trial]

Source context — Nasal pt141 is amazing: Promotion-oriented forum with guide/vendor references; sponsorship not established. No product testing, calibrated pump output or dosing schedule. Approximate total is transparent arithmetic on nominal claims, not absorbed mass. Husband's next-morning onset is spouse-reported.

Half-life, onset & duration

Felt onset	Different users describe 10 minutes, 30–45 minutes or about an hour. A spouse report says next morning.
Felt duration	One brief account says about 20 minutes; another still felt sensitivity eight hours later. Overnight and next-day effects also appear without calibrated amounts.
Half-life	1.85–2.09 hours in a historical male nasal study, not measured in current community sprays. The injection's 2.7-hour value is route-specific.
Blood peak	Median 0.5 hour in the historical nasal study. This is study-formulation PK, not a dependable countdown to a modern spray's effect.

Notes

10 minutes, 30–45 minutes or about an hour. Those estimates come from three different nasal accounts. The first included warmth and tired relaxation; the others described sexual effects. Preserved planning talk allows 30–60+ minutes, but that is a convention rather than a dependable countdown. Interesting experience with Pt 141 nasal spray (Community discussion · Accessed 2026-09-30) · PT-141 experience (Community discussion · Accessed 2026-09-30) · Nasal pt141 is amazing (Community discussion · Accessed 2026-09-30)

Sometimes the next morning, sometimes nothing. The hour-onset author's husband reportedly noticed it next morning. Nonresponders describe repeated attempts without a useful onset. Congestion, drip and uneven delivery are discussed confounders; none was measured in these accounts. Nasal pt141 is amazing (Community discussion · Accessed 2026-09-30) · Does PT-141 work? — nasal nonresponse replies (Community discussion · Accessed 2026-09-30)

Brief response and lingering sensitivity differ. The 1.25 mg author described about 20 minutes of effects. Another nasal user still felt sensitivity eight hours later, inconveniently at work. Older community notes describe several same-day hours; none establishes a standard window. Interesting experience with Pt 141 nasal spray (Community discussion · Accessed 2026-09-30) · Female PT-141 experiences and compounded nasal replies (Community discussion · Accessed 2026-09-30)

Overnight reports also exist. An enthusiastic nasal author described drive throughout the night and lingering effects next day, without a timed onset or calibrated milligrams. Overnight benefit is possible in the account, not a typical duration or continuous erection. PT-141 is a 10 out of 10 for me (Community discussion · Accessed 2026-09-30)

No community-measured nasal half-life. Opened nasal accounts describe sensations, not serial blood levels. The preserved record distinguishes felt effects from plasma clearance. An effect fading in 20 minutes, persisting eight hours or appearing next morning cannot supply a half-life or redosing interval. Interesting experience with Pt 141 nasal spray (Community discussion · Accessed 2026-09-30) · Female PT-141 experiences and compounded nasal replies (Community discussion · Accessed 2026-09-30) · Nasal pt141 is amazing (Community discussion · Accessed 2026-09-30)

Measured nasal kinetics are study-formulation data. Diamond's 2004 male study abstract reports mean half-life 1.85–2.09 hours and median plasma peak at 0.5 hour. Erectile responses were significant above 7 mg, with first erections around 30 minutes. These are formal human findings, not current spray measurements. Diamond et al. 2004 intranasal PT-141 study abstract (Official context · Accessed 2026-09-30)

The injection comparator is route-specific. Vyleesi's measured terminal half-life averages 2.7 hours; efficacy duration is unknown. Its 1.75 mg subcutaneous amount and frequency limits do not convert into nasal milligrams. Vyleesi bremelanotide injection prescribing information (Official context · Accessed 2026-09-30)

Source context — PT-141 is a 10 out of 10 for me: Enthusiastic product-oriented discussion, no verified sponsorship or dose. Deleted intervening prompts limit concentration context; do not derive milligrams. OP says never injected then makes a confusing injection comparison; only explicit nasal description retained. Unsupported 40% nonresponder reply not used.

Source context — Diamond et al. 2004 intranasal PT-141 study abstract: Abstract reviewed, not full text; healthy men and sildenafil-responsive ED patients, controlled historical formulation. No modern spray conversion or safety assurance.

Cycles people discuss

Event-tied use	Date-night/weekend use appears; no established nasal loading or weeks-on/weeks-off cycle emerges. Symptoms, cost or no response can end use.
Borrowed frequency caps	Once per 24 hours and eight per month come from the injection label. A clinic's three uses weekly could exceed eight monthly; neither validates nasal frequency.

Notes

Event-tied use, no established loading cycle. Preserved discussion centers on date nights and weekends; nausea, blood-pressure concerns, irritation, cost or no response can end use. A fresh author planned another attempt in a few days. No supported nasal weeks-on, weeks-off schedule emerges. PT-141 is a 10 out of 10 for me (Community discussion · Accessed 2026-09-30)

Weekly scripts and monthly caps are different. The recorded clinic ceiling of three uses weekly could exceed eight monthly. Once-per-24-hour and eight-per-month figures originate in the injection label, then get borrowed for sprays. Borrowing them does not validate nasal frequency or tolerance prevention.

Stacks

Sildenafil or tadalafil	These recur alongside desire-focused PT-141. Historical controlled combinations do not establish safety or dose equivalence for current sprays.
Other sexual-hormone agents	Oxytocin, kisspeptin and hormone treatment appear in broader accounts. Melanotan II overlap raises nausea, blood-pressure and pigmentation concerns.
Nausea workarounds	Ondansetron, ginger or antihistamines are discussed. One user had nausea on one of two attempts despite ondansetron beforehand.

Notes

+ PDE5 inhibitors (sildenafil / tadalafil): Most discussed practical stack — central desire (melanocortin) + peripheral erection blood-flow (PDE5). Historical IN PT-141 + sildenafil co-admin trials support enhanced erectile activity vs PDE5 alone in controlled RigiScan designs. [trial]

Stacks blur what caused the change. Preserved discussion pairs sildenafil or tadalafil with desire-focused PT-141, compares kisspeptin and oxytocin, and questions overlapping nausea, blood-pressure and pigmentation effects with Melanotan II. A fresh multi-compound account includes hormone treatment. Sleep, relationships, alcohol and medications also complicate attribution; combinations cannot isolate a nasal effect. Community libido discussion with multi-compound account (Community discussion · Accessed 2026-09-30)

Comment at lines 153–156 naming nasal oxytocin, injected kisspeptin, nasal or injected PT-141, hormone pellets and other co-use. Community libido discussion with multi-compound account (Community discussion · Accessed 2026-09-30)

Nausea workarounds are reports, not prevention guarantees. The eight-hour nasal account used ondansetron before both attempts but had nausea on one. Other discussion mentions ginger or antihistamines. Product-specific storage and identity questions remain; neither a workaround nor forum mixing arithmetic verifies a bottle. Female PT-141 experiences and compounded nasal replies (Community discussion · Accessed 2026-09-30) · PT-141 experience (Community discussion · Accessed 2026-09-30)

Source context — Community libido discussion with multi-compound account: Route alternates, no component amounts or isolated response. Adjacent cycling sentence refers to l-tyrosine and is not attributed to PT-141. No regimen, sourcing or claimed safety adopted.

Watch for

Burning and nausea	Burning, hot flushing and nausea can occur without desired effects; those sensations do not verify effective delivery.
Blood pressure and absorption	Blood-pressure increases and variable nasal uptake were part of the sponsor's explanation for ending first-line nasal development.
Medical interaction context	Injection warnings include blood-pressure/heart-rate changes, cardiovascular contraindications, potentially lasting pigmentation, oral naltrexone exposure changes and pregnancy concerns.
Concern notice	The often-cited 10 mg sildenafil-failure trial has a linked expression of concern; it cannot establish a dependable modern spray dosing rule.

Notes

Blood-pressure history matters. Palatin reported blood-pressure increases and variable nasal uptake when explaining discontinuation of nasal development as first-line sexual-dysfunction therapy. That history contradicts the idea that avoiding needles makes systemic exposure harmless. Palatin 2009 Form 10-K — nasal development history (Official context · Accessed 2026-09-30)

Injection warnings remain relevant context. Vyleesi raises blood pressure and lowers heart rate; uncontrolled hypertension or cardiovascular disease contraindicate it. Pigmentation can persist. Oral-drug absorption, especially naltrexone, and pregnancy require medical attention. Nasal product risks are not established by injection percentages. Vyleesi bremelanotide injection prescribing information (Official context · Accessed 2026-09-30)

The frequently cited 10 mg trial has a concern notice. The sildenafil-failure study reported 33.5% positive clinical results versus 8.5% with placebo. PubMed links a 2023 expression of concern. Its 10 mg intranasal formulation and results should not establish a modern dosing rule or promised rescue effect. Safarinejad and Hosseini 2008 salvage study and linked expression of concern (Official context · Accessed 2026-09-30)

Source context — Palatin 2009 Form 10-K — nasal development history: Sponsor's historical account with commercial interest; variability explanation includes a stated hypothesis. Not an independent modern-spray outcome study.

Source context — Safarinejad and Hosseini 2008 salvage study and linked expression of concern: Original abstract and concern indexing reviewed; notice body not available through direct open. No inference about misconduct or specific notice reasons. Results qualified by concern, not accepted as dependable efficacy estimates.

Full notes

What the nasal version is

Same peptide, different delivery. Bremelanotide activates melanocortin receptors, including receptors in the brain; its exact desire mechanism is unknown. Vyleesi is an injection for specified premenopausal low-desire disorder, not a nasal performance product. Official context
Needle avoidance drives interest. People compare ready-made sprays, compounded liquids and improvised research sprays. A Drugs-Forum writer explicitly feared needles but obtained no effect nasally. Formulation, actuation and absorption make a spray count different from a known absorbed amount. Personal report Community

What people hope to feel

More interest or responsiveness. One nasal user described relaxation, warmth and easier sexual response; another described optimism and heightened touch sensitivity. These are different experiences, not proof that every spray produces desire or fixes erectile dysfunction. Reddit r/pt141info Reddit r/BiohackingU
Less nausea for some, unchanged for others. A route-comparison author reported strong sexual effects without the nausea experienced with injection. Elsewhere, four nasal sprays produced flushing and brief nausea but no desired change. A route switch does not predict tolerability or benefit. Reddit r/pt141info Reddit r/BiohackingU

Doses in nasal discussion

Nominal 1.25 mg versus 2 mg per occasion. One author claimed 1.25 mg across six sprays and a brief response; replies disputed the concentration. A different commenter reported no effect from two sprays labeled 1 mg each. These are separate unverified totals, not a useful dose ladder. Reddit r/pt141info
100 mcg per spray, opposite outcomes. Another author reported four to five 100 mcg sprays, nominally 400–500 mcg total, with benefit. A couple using a 100 mcg-per-spray product reported none, without giving their total. Per-spray strength alone cannot compare exposures. Reddit r/BodyHackGuide
Clinic scripts are another source of numbers. The original clinic/community record includes a 1 mg-per-spray script with a 2 mg-per-occasion ceiling and broader 0.5–2 mg per-spray claims. These commercial conventions are not measured responder bands; old multi-milligram trial formulations cannot calibrate today's bottle. Community

Half-life: what discussion cannot measure

No community-measured nasal half-life. Opened nasal accounts describe sensations, not serial blood levels. The preserved record distinguishes felt effects from plasma clearance. An effect fading in 20 minutes, persisting eight hours or appearing next morning cannot supply a half-life or redosing interval. Community Reddit r/pt141info Reddit r/BiohackingU Reddit r/BodyHackGuide

When effects are reported

10 minutes, 30–45 minutes or about an hour. Those estimates come from three different nasal accounts. The first included warmth and tired relaxation; the others described sexual effects. Preserved planning talk allows 30–60+ minutes, but that is a convention rather than a dependable countdown. Reddit r/pt141info Reddit r/pt141info Reddit r/BodyHackGuide Community
Sometimes the next morning, sometimes nothing. The hour-onset author's husband reportedly noticed it next morning. Nonresponders describe repeated attempts without a useful onset. Congestion, drip and uneven delivery are discussed confounders; none was measured in these accounts. Reddit r/BodyHackGuide Reddit r/Biohacking Community

How long the experience lasts

Brief response and lingering sensitivity differ. The 1.25 mg author described about 20 minutes of effects. Another nasal user still felt sensitivity eight hours later, inconveniently at work. Older community notes describe several same-day hours; none establishes a standard window. Reddit r/pt141info Reddit r/BiohackingU Community
Overnight reports also exist. An enthusiastic nasal author described drive throughout the night and lingering effects next day, without a timed onset or calibrated milligrams. Overnight benefit is possible in the account, not a typical duration or continuous erection. Reddit r/NTNPerformance

Frequency and breaks

Event-tied use, no established loading cycle. Preserved discussion centers on date nights and weekends; nausea, blood-pressure concerns, irritation, cost or no response can end use. A fresh author planned another attempt in a few days. No supported nasal weeks-on, weeks-off schedule emerges. Community Reddit r/NTNPerformance
Weekly scripts and monthly caps are different. The recorded clinic ceiling of three uses weekly could exceed eight monthly. Once-per-24-hour and eight-per-month figures originate in the injection label, then get borrowed for sprays. Borrowing them does not validate nasal frequency or tolerance prevention. Community

Adverse effects and safety limits

Burning and flushing can occur without benefit. One nasal user described intense burning for several minutes and discarded the spray after repeated failures. Another experienced hot flushing and ten minutes of nausea, then nothing. Feeling a side effect does not confirm effective delivery. Reddit r/Biohacking Reddit r/BiohackingU
Blood-pressure history matters. Palatin reported blood-pressure increases and variable nasal uptake when explaining discontinuation of nasal development as first-line sexual-dysfunction therapy. That history contradicts the idea that avoiding needles makes systemic exposure harmless. Official context
Injection warnings remain relevant context. Vyleesi raises blood pressure and lowers heart rate; uncontrolled hypertension or cardiovascular disease contraindicate it. Pigmentation can persist. Oral-drug absorption, especially naltrexone, and pregnancy require medical attention. Nasal product risks are not established by injection percentages. Official context

Historical studies, kept separate

Measured nasal kinetics are study-formulation data. Diamond's 2004 male study abstract reports mean half-life 1.85–2.09 hours and median plasma peak at 0.5 hour. Erectile responses were significant above 7 mg, with first erections around 30 minutes. These are formal human findings, not current spray measurements. Official context
The frequently cited 10 mg trial has a concern notice. The sildenafil-failure study reported 33.5% positive clinical results versus 8.5% with placebo. PubMed links a 2023 expression of concern. Its 10 mg intranasal formulation and results should not establish a modern dosing rule or promised rescue effect. Official context
The injection comparator is route-specific. Vyleesi's measured terminal half-life averages 2.7 hours; efficacy duration is unknown. Its 1.75 mg subcutaneous amount and frequency limits do not convert into nasal milligrams. Official context

What the mixed accounts help explain

Needle-free convenience is a tradeoff. Some writers prefer sprays; others abandon them after no response. The enthusiastic overnight author later mentions five sprays and the inconvenience of spray counts. A pleasant first account and a failed bottle do not establish overall success rates. Reddit r/NTNPerformance Reddit r/Biohacking
A weak product is only one explanation. Forums blame concentration, ingredients, congestion or product identity. The Drugs-Forum writer suspected an incompatible liquid after observing particles, without testing that explanation. Peptide Critic's blanket molecular-size dismissal likewise exceeds what its single failed nasal account establishes. Personal report Peptide Critic Community Community
Stacks blur what caused the change. Preserved discussion pairs sildenafil or tadalafil with desire-focused PT-141, compares kisspeptin and oxytocin, and questions overlapping nausea, blood-pressure and pigmentation effects with Melanotan II. A fresh multi-compound account includes hormone treatment. Sleep, relationships, alcohol and medications also complicate attribution; combinations cannot isolate a nasal effect. Community Reddit r/Biohackers
Nausea workarounds are reports, not prevention guarantees. The eight-hour nasal account used ondansetron before both attempts but had nausea on one. Other discussion mentions ginger or antihistamines. Product-specific storage and identity questions remain; neither a workaround nor forum mixing arithmetic verifies a bottle. Reddit r/BiohackingU Reddit r/pt141info Community